preeclampsia: Preeclampsia is a hypertensive disorder of pregnancy that is characterized by new-onset hypertension with proteinuria presenting after 20 weeks of gestation, and depending on mild or severe forms may initially present with severe headache, visual disturbances, and hyperreflexia.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
437 |
4. Check minimum number of eventsNone |
437 |
5. Include endpointsNone |
437 |
6. Filter based on genotype QC (FinnGen only) |
437 |
Control definitions (FinnGen only)
- Control exclude
- O15_OEDEM_PROTUR_HYPERT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O10-O16
- Name in latin
- Hypertensio graviditatis non specificata
Similar endpoints
↥List of similar endpoints to
Unspecified maternal hypertension
based on the number of shared cases.
Similar with more cases:
- Pregnancy hypertension
- Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2797 | 2797 | - |
| Only index persons | 2780 | 2780 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | - |
| Only index persons | 0.10 | 0.10 | - |
| Median age at first event (years) | |||
| Whole population | - | 30.63 | - |
| Only index persons | - | 30.63 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 437 | 437 | - |
| Unadjusted period prevalence (%) | 0.15 | 0.15 | - |
| Median age at first event (years) | 30.97 | 30.97 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 382
- Matched controls
- 3818
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O16
ICD-10 Finland
Unspecified maternal hypertension
+∞
323.0
346
*
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
1260.6
169.5
153
*
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
+∞
62.2
58
*
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
+∞
60.0
56
*
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
5.5
44.0
160
440
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.6
40.1
138
349
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
+∞
33.8
32
*
6429A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Unspecified hypertension complicating pregnancy, childbirth, or the puerperium[HYPERTENSIO GRAVIDARUM NUD,ENNEN SYNNYTYSTÄ]
+∞
32.8
31
*
C07AG01
ATC
labetalol; systemic
56.5
30.9
36
7
O14.1
ICD-10 Finland
Severe pre-eclampsia
+∞
28.5
27
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
3.0
23.4
250
1466
I10
ICD-10 Finland
Essential (primary) hypertension
3.4
21.7
127
486
SPAT1324
SPAT
Screening procedure
2.8
20.3
184
941
ZXD05
NOMESCO Finland
Urgent procedure
2.7
18.8
185
981
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
3.3
18.2
109
414
C09CA01
ATC
losartan; oral
4.0
16.1
70
205
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.8
15.8
121
538
205
Kela drug reimbursment
Chronic hypertension
5.4
14.7
45
92
O80.9
ICD-10 Finland
Single spontaneous delivery, unspecified
8.3
14.2
31
40
C08CA05
ATC
nifedipine; systemic
6.4
14.0
37
63
MAC96
NOMESCO Finland
Other induction or advancement of labour
4.6
12.9
45
107
W84
ICPC
Pregnancy high risk
4.0
12.5
51
141
C09AA02
ATC
enalapril; systemic
4.7
12.2
42
98
SPAT1210
SPAT
Application of cast or individual aid
6.5
12.1
31
51
SPAT1357
SPAT
Monitoring of problem during pregnancy
4.2
11.1
43
113
OAA41
SPAT
NA
11.0
10.4
19
18
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
2.9
10.1
65
253
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
4.1
10.1
39
103
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.4
9.5
90
433
6424A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]
+∞
9.4
9
*
C07AB07
ATC
bisoprolol; oral
2.2
9.0
103
543
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
8.7
179
1197
E66.9
ICD-10 Finland
Obesity, unspecified
4.4
8.6
30
72
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
13.2
8.4
14
11
C07AB02
ATC
metoprolol; systemic
2.9
7.9
47
174
WX234
NOMESCO Finland
Paracervical blockade
3.5
7.9
36
110
SPAT1316
SPAT
Extensive health check-up of children and adolescents
3.5
7.7
35
107
O12.0
ICD-10 Finland
Gestational oedema
81.6
7.4
8
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
6.5
7.3
18
29
6423A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]
+∞
7.3
7
*
O10.9
ICD-10 Finland
Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
O12.1
ICD-10 Finland
Gestational proteinuria
+∞
7.3
7
*
K85
ICPC
Elevated blood pressure
3.5
7.2
32
97
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.6
7.1
54
230
C08CA01
ATC
amlodipine; oral
2.5
7.0
54
233
-
ICD-10 Finland
NA
7.8
7.0
15
20
SPAT1379
SPAT
Health check-up of pregnant person
2.0
6.9
98
560
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.0
6.8
92
516
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.4
6.5
58
269
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
3.6
6.4
27
79
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
2.1
6.2
79
428
SPAT1301
SPAT
No procedures
1.9
6.1
111
690
SPAT1263
SPAT
Sampling
1.7
6.1
169
1200
SPAT1312
SPAT
General health counselling
1.8
6.1
132
870
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.8
6.1
115
724
O99.80
ICD-10 Finland
The fear of childbirth
2.3
6.1
54
252
SPAT1380
SPAT
Postpartum check-up
2.0
6.0
85
484
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
140
303
6.33
65.66
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
122
291
5.43
50.33
5.1
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
84
207
4.79
32.46
3.3
3.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
180
767
3.29
31.32
4.4
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
167
748
3.00
25.75
4.6
3.1
kg/l
1.0
1.0
—
8
89
(3020891) Body temperature
38
59
6.96
23.85
3.2
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
177
937
2.49
18.43
4.6
3.1
estimate
0.0
0.0
1.08
31
356
(3019060) Gas panel - Arterial blood
40
94
4.58
16.08
4.2
10.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
39
93
4.51
15.39
5.0
9.7
%
93.6
94.9
0.51
39
93
(3015736) pH of Urine
225
1414
2.22
14.87
4.0
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
110
510
2.55
14.74
3.6
3.9
mg/mmol
16.5
6.8
1.04
84
311
(3012516) Albumin [Mass/volume] in Urine
106
492
2.52
14.12
3.4
3.2
mg/l
80.8
286.5
0.57
85
295
(3026493) Urate [Moles/volume] in Serum or Plasma
127
656
2.32
13.25
2.3
1.9
umol/l
308.5
3931.2
2.03
122
603
(3035350) Ketones [Presence] in Urine by Test strip
258
1810
2.04
11.72
4.3
2.9
estimate
0.0
0.0
0.00
30
343
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
216
1435
2.00
11.32
4.0
2.8
—
—
—
0
0
(3044889) 12 lead EKG panel
286
2101
2.05
11.20
2.9
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
256
1812
2.00
11.10
5.1
4.0
estimate
0.0
0.0
0.50
33
358
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
162
977
2.05
11.10
3.3
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
88
420
2.37
10.81
1.8
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
58
235
2.69
10.02
2.3
2.2
ml/min/173m2
79.8
86.9
0.73
15
85
(3009508) Creatinine [Moles/volume] in Urine
119
662
2.10
9.98
3.3
2.9
mmol/l
8.3
7.8
0.54
111
582
(3009261) Glucose [Presence] in Urine by Test strip
253
1838
1.89
9.57
4.3
2.9
estimate
0.0
0.0
0.78
33
350
(3003396) Base excess in Arterial blood by calculation
49
186
2.84
9.57
6.1
10.0
mmol/l
0.5
1.0
0.35
30
129
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
25
67
3.90
8.46
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
77
387
2.20
8.26
1.8
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
88
3.46
8.22
2.6
3.2
g/l
0.1
0.4
0.88
18
34
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
105
599
1.99
8.04
2.1
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
107
632
1.92
7.34
1.6
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
53
256
2.22
6.23
2.3
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
63
326
2.09
6.22
1.7
2.0
s
27.6
29.1
2.37
63
318
(3023103) Potassium [Moles/volume] in Serum or Plasma
393
3494
2.24
6.22
9.9
8.4
mmol/l
3.9
3.9
1.95
385
3389
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
69
3.30
5.95
2.3
2.0
%
1.7
1.4
0.38
22
69
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
846
1.73
5.94
1.8
1.7
mg/l
1.1
0.6
1.98
101
618
(3019550) Sodium [Moles/volume] in Serum or Plasma
391
3486
2.16
5.87
10.0
8.4
mmol/l
139.3
139.5
1.68
383
3394
(4034850)
29
112
2.70
5.51
8.4
7.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
38
4.05
5.48
1.1
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
45
215
2.22
5.43
1.4
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
114
1632
0.59
5.40
4.7
5.3
%
0.6
0.7
0.59
104
1523
(3006504) Eosinophils/100 leukocytes in Blood
121
1698
0.60
5.24
4.6
5.2
%
2.5
2.7
0.26
115
1588
(3002030) Lymphocytes/100 leukocytes in Blood
129
1772
0.61
5.06
4.6
5.2
%
28.3
29.9
1.05
122
1675
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
159
1155
1.59
4.96
1.9
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
79
478
1.80
4.90
2.7
2.1
u/l
12903.2
4075.2
0.86
26
186
(3013826) Glucose [Moles/volume] in Serum or Plasma
215
1677
1.56
4.89
4.6
4.0
mmol/l
6.4
6.2
1.14
187
1494
(3024561) Albumin [Mass/volume] in Serum or Plasma
153
1111
1.58
4.74
3.7
4.2
g/l
35.6
37.2
2.62
147
1049
(3018010) Neutrophils/100 leukocytes in Blood
130
1759
0.63
4.64
4.2
5.0
%
58.6
56.6
1.19
124
1665
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
70
416
1.81
4.60
2.7
2.2
e6/l
1.7
1.0
0.54
47
218
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
124
871
1.59
4.37
2.8
2.4
ng/l
95.8
16.2
0.43
43
304
(3019069) Monocytes/100 leukocytes in Blood
126
1700
0.64
4.35
4.7
5.4
%
7.3
7.7
0.73
120
1607
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
373
3351
1.77
4.34
3.4
2.8
mmol/l
1.3
1.2
2.56
364
3212
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
96
2.59
4.29
2.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
359
3204
1.67
4.13
4.8
4.4
pmol/l
14.6
14.2
3.31
344
3059
(3036489) Thrombin time
30
141
2.21
3.80
1.5
1.9
s
24.9
20.3
0.61
24
120
(3002256) Pathology report gross observation
21
462
0.43
3.73
1.1
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
300
3352
0.67
3.66
11.3
11.0
%
13.5
13.5
0.03
295
3297
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
368
3339
1.65
3.57
3.6
3.1
mmol/l
5.5
5.5
0.19
351
3181
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
125
2.24
3.56
2.9
2.2
umol/l
4.3
4.3
0.01
18
91
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
382
3501
1.72
3.55
3.6
3.1
mmol/l
1.5
1.6
4.47
373
3369
(4010399)
38
203
1.95
3.47
1.1
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
382
3513
1.69
3.34
3.7
3.1
mmol/l
4.8
4.8
0.03
371
3389
(3000991) Gas panel - Venous blood
27
129
2.17
3.31
6.9
7.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
75
1079
0.63
3.26
5.0
5.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
389
3605
1.72
3.17
5.4
5.0
mu/l
1.7
2.0
0.49
375
3472
(3026008) Bacteria identified in Urine by Culture
123
918
1.47
3.16
2.8
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
68
2.56
3.08
1.3
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
81
559
1.55
3.01
2.1
2.2
e6/l
7.7
10.0
0.58
72
489
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
35
3.20
2.95
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
382
3538
1.63
2.94
4.0
3.3
mmol/l
3.0
2.9
1.48
370
3396
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
159
1260
1.41
2.93
1.7
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
49
300
1.71
2.93
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
48
294
1.71
2.87
1.7
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
128
982
1.43
2.81
3.9
3.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
168
1355
1.39
2.76
1.7
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
399
3749
1.74
2.75
10.4
9.3
mg/l
15.9
17.6
0.69
313
2824
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
14
5.06
2.74
1.4
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
14
5.06
2.74
3.6
1.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
14
5.06
2.74
1.4
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
29
154
1.95
2.73
3.6
7.3
mmol/l
5.5
6.5
0.55
29
148
(3030467) Casts [#/volume] in Urine by Automated count
100
737
1.46
2.71
2.9
2.5
e6/l
0.2
0.3
0.16
78
539
(3004716) Salmonella sp identified in Stool by Organism specific culture
47
291
1.69
2.71
1.4
1.5
—
—
—
0
0
(3012544) pH of Venous blood
29
155
1.93
2.68
2.6
2.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
20
389
0.49
2.57
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
126
978
1.41
2.57
1.9
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
50
2.65
2.55
1.1
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
28
152
1.90
2.49
1.7
2.1
g/l
66.3
67.9
0.68
28
141
(3043238) Trisomy 21 risk [Likelihood] in Fetus
48
307
1.63
2.46
1.4
1.5
—
—
—
0
0
(4035726)
10
249
0.39
2.43
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
100
752
1.43
2.42
2.8
2.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
54
357
1.58
2.42
1.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
79
568
1.48
2.42
2.2
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
54
358
1.58
2.39
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
54
359
1.58
2.37
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
47
302
1.62
2.37
1.4
1.4
—
—
—
0
0
(3013512) EKG study
40
621
0.61
2.36
2.0
2.4
—
—
—
0
0
(44813793)
10
35
2.90
2.32
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
27
149
1.87
2.30
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
281
2505
1.34
2.25
4.5
3.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
62
0.00
2.24
0.0
6.7
—
364.4
—
0
53
(3014111) Lactate [Moles/volume] in Serum or Plasma
28
158
1.83
2.23
6.3
5.7
mmol/l
1.2
1.2
0.09
28
152
(3009542) Hematocrit [Volume Fraction] of Blood
347
3696
0.70
2.23
10.7
10.0
%
39.3
39.6
0.34
285
3182
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
53
357
1.55
2.21
1.5
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
120
947
1.37
2.18
3.0
2.4
u/l
56.1
55.3
0.07
110
893
(3021589) Normoblasts [#/volume] in Blood
129
1578
0.74
2.15
6.2
7.0
e9/l
0.0
0.0
0.65
103
1304
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
37
2.74
2.11
1.5
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
43
2.60
2.11
1.5
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
55
378
1.52
2.10
1.4
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
18
89
2.07
2.09
1.2
1.5
mmol/l
3.5
3.5
0.03
18
84
(3045414) Leukocytes [Presence] in Urine
29
170
1.76
2.06
2.0
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
150
1.78
1.95
2.7
2.7
mmol/l
1.7
1.6
0.07
19
117
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
11
4.58
1.94
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
416
4004
1.81
1.93
10.2
8.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
133
1087
1.32
1.89
3.4
3.0
e6/l
29.3
38.3
0.32
84
666
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
95
738
1.37
1.89
2.8
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
137
1.80
1.87
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
28
2.89
1.87
1.3
2.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
225
1.60
1.80
1.3
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
60
2.20
1.79
1.5
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
18
3.36
1.75
4.8
3.3
u/ml
966.3
446.0
—
6
18
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
31
2.61
1.66
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
76
2.01
1.66
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
201
1759
1.26
1.64
4.2
3.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
291
2662
1.28
1.64
3.3
3.5
mm/h
9.3
8.7
0.64
275
2529
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
32
2.53
1.60
1.6
1.5
pmol/l
249.6
358.9
—
8
19
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
152
1.68
1.60
2.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
437
0.64
1.54
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
15
3.36
1.52
1.0
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
21
2.88
1.51
1.3
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
45
0.00
1.50
0.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
39
547
0.68
1.46
1.4
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
28
2.52
1.45
1.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
163
1408
1.25
1.45
2.2
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
66
2.00
1.45
3.1
2.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
358
0.62
1.41
2.7
1.7
—
—
—
0
0
(4306422)
14
74
1.92
1.40
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
120
0.41
1.39
1.0
1.3
—
2.4
—
0
13
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
123
0.40
1.39
1.0
1.3
—
17.4
—
0
28
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
23
2.63
1.37
1.0
1.2
miu/ml
3122.5
1727.8
—
6
23
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
320
2990
1.26
1.36
4.3
3.6
mmol/mol
37.4
36.9
0.55
310
2871
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
177
1553
1.23
1.35
5.1
5.0
umol/l
8.8
9.2
0.28
163
1466
(3000494) Fungus identified in Specimen by Culture
24
365
0.64
1.34
1.3
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
352
0.63
1.32
1.1
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
134
0.44
1.30
1.2
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
131
1117
1.25
1.29
4.6
4.7
mmol/l
1.2
1.2
4.54
126
1030
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
102
846
1.27
1.27
2.2
2.0
mg/l
3.1
2.5
1.92
97
732
(3001019) Free T4 and TSH panel - Serum or Plasma
35
487
0.69
1.27
1.2
1.7
—
—
—
0
0
(3019225) pH of Specimen
15
250
0.59
1.23
1.5
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
80
647
1.29
1.22
1.9
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
237
0.58
1.22
3.2
2.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
76
933
0.78
1.22
1.3
1.4
g/l
2.2
2.0
0.28
58
620
(40761536) Microorganisms panel - Urine sediment
21
316
0.65
1.14
3.0
3.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
430
4233
1.99
1.11
16.5
13.9
fl
89.3
90.0
2.99
430
4198
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
81
1.75
1.10
1.9
1.8
mmol/l
7.6
7.4
—
6
49
(3002523) Influenza virus A Ag [Presence] in Specimen
6
123
0.48
1.06
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
123
0.48
1.06
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
33
2.14
1.06
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
238
0.62
1.04
2.7
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
155
1.51
1.03
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
36
266
1.39
1.02
3.6
5.2
mmol/l
1.0
1.0
0.21
36
247
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
109
0.45
1.02
3.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
91
1.67
1.02
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
133
0.52
1.00
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
430
4237
1.93
1.00
16.6
14.0
g/l
133.3
133.2
0.07
430
4204
(3035941) MCH [Entitic mass]
430
4235
1.96
1.00
16.5
13.8
pg
29.8
30.0
1.25
430
4199
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
92
1.65
0.98
4.7
2.7
mg/l
9.9
9.1
0.21
15
83
(3025941) Bacteria identified in Stool by Culture
17
257
0.65
0.96
1.4
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
142
0.56
0.95
2.6
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
94
1095
0.82
0.94
1.7
1.7
pmol/l
98.6
99.5
0.07
55
637
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
64
777
0.79
0.94
1.5
1.6
mmol/l
1.4
1.3
0.44
59
711
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
78
1.69
0.92
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
94
803
1.22
0.91
1.7
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
401
0.73
0.89
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
96
1107
0.83
0.87
2.4
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
80
1.64
0.85
1.2
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
26
188
1.41
0.85
1.0
1.3
u/ml
0.4
2.5
—
5
12
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
31
1.95
0.84
1.2
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
147
1.45
0.81
1.2
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
47
1.71
0.81
1.9
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
175
0.62
0.80
1.6
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
74
1.64
0.79
1.2
1.2
u/ml
100.4
217.2
—
7
53
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
82
1.60
0.79
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
95
825
1.19
0.78
3.2
2.6
e6/l
12.6
103.5
1.62
73
609
(21494815) CD4 cells/100 lymphocytes in Specimen
0
28
0.00
0.76
0.0
2.6
—
42.0
—
0
5
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
28
0.00
0.76
0.0
1.2
—
31.2
—
0
28
(3022806) Fractional oxyhemoglobin in Capillary blood
5
24
2.10
0.74
1.0
1.5
%
91.8
91.5
—
5
24
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
241
0.69
0.73
4.6
1.8
mg/l
5.5
2.8
0.37
12
158
(3027135) IgG subclass 1 [Mass/volume] in Serum
7
39
1.81
0.73
1.1
1.4
g/l
7.1
6.0
—
7
28
(3028192) IgG subclass 2 [Mass/volume] in Serum
7
39
1.81
0.73
1.1
1.4
g/l
3.4
2.7
—
7
27
(4062490)
7
39
1.81
0.73
1.1
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
7
39
1.81
0.73
1.1
1.4
g/l
0.3
0.4
—
7
28
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
76
1.60
0.72
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
178
1.37
0.70
1.2
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
144
1.41
0.69
2.1
2.3
iu/l
2.4
5.9
—
9
66
(3024980) IgG subclass 4 [Mass/volume] in Serum
10
61
1.65
0.69
1.1
1.4
g/l
0.7
0.6
—
10
46
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
11
168
0.65
0.69
1.5
2.7
mmol/l
1.2
1.2
0.95
11
141
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
223
1.32
0.68
1.3
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
129
0.61
0.65
2.9
2.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
142
1295
1.14
0.63
4.6
5.4
mmol/l
1.2
1.2
2.30
134
1112
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
97
1087
0.86
0.62
1.2
1.3
u/ml
0.6
1.4
1.21
35
301
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
63
1.60
0.62
1.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
549
1.19
0.62
3.3
3.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
85
749
1.17
0.60
2.5
3.0
ph
7.4
7.4
—
8
126
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
3.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
8
52
1.55
0.59
1.0
1.1
—
0.3
—
0
21
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
44
365
1.23
0.59
3.8
2.6
ng/l
275.8
612.0
0.84
38
296
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
23
0.00
0.58
0.0
1.8
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
7
116
0.60
0.58
1.9
2.9
e6/l
0.2
0.1
—
7
110
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
73
1.52
0.56
1.5
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
133
1.37
0.56
1.1
1.1
u/ml
0.9
4.6
—
7
65
(3000330) Specific gravity of Urine by Test strip
8
125
0.63
0.55
3.1
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
116
1.39
0.55
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
60
1.51
0.54
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
38
1.59
0.54
1.5
1.3
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
9
61
1.49
0.54
1.7
1.4
nmol/l
29.5
32.3
—
9
47
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
39
1.55
0.53
1.2
1.5
u/ml
3.2
4.8
—
6
30
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
269
1.25
0.53
1.5
1.4
miu/ml
258.8
234.6
0.14
17
147
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
9
135
0.66
0.52
1.1
1.3
—
23.9
—
0
8
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
40
1.51
0.52
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
64
1.41
0.51
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
400
1.20
0.51
1.7
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
150
1611
0.90
0.50
1.7
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
119
1.36
0.49
1.1
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
46
1.53
0.48
1.3
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
85
1.42
0.47
1.0
1.1
—
12.3
—
0
8
(1761868) Lipid panel - Serum or Plasma
143
1535
0.90
0.47
1.8
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
48
1.47
0.47
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
108
987
1.13
0.47
2.0
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
84
756
1.14
0.46
1.3
1.3
u/ml
7.3
12.3
0.36
48
330
(3011288) Drugs identified in Urine by Screen method
15
198
0.75
0.46
3.0
2.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
17
220
0.76
0.46
2.3
2.3
g/l
0.2
0.2
0.11
17
211
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
103
1.37
0.45
4.5
5.8
mmol/l
23.6
24.4
0.51
14
103
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
7
50
1.41
0.45
1.9
1.7
—
10.7
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
121
1117
1.12
0.44
2.0
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
113
1.34
0.43
1.0
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
41
351
1.19
0.43
1.5
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
94
0.63
0.42
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
531
1.15
0.42
1.3
1.5
%
1.3
1.3
0.02
55
489
(44806118)
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(44790048)
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(44790049)
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(44790047)
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
216
2060
1.10
0.41
6.4
7.9
e9/l
4.4
4.0
1.91
193
1828
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
183
0.76
0.41
1.6
1.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
100.3
—
0
15
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
16
0.00
0.41
0.0
2.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
775
1.12
0.39
1.3
1.3
iu/ml
20.0
22.0
0.10
21
248
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
6.6
—
162.5
—
0
13
(3022621) pH of Urine by Test strip
17
214
0.79
0.39
4.4
2.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
80
1.38
0.38
1.9
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
89
1.36
0.38
15.0
15.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
111
0.72
0.37
1.1
1.3
—
24.8
—
0
9
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
116
1.30
0.37
1.1
1.2
—
—
—
0
0
(4094501)
9
70
1.29
0.37
1.1
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
81
740
1.12
0.36
2.7
3.2
%
101.8
99.5
0.43
75
719
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
298
0.83
0.36
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
292
1.18
0.36
1.4
1.5
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
42
1.43
0.35
1.5
1.9
kpa
5.2
5.0
—
6
42
(3027315) Oxygen [Partial pressure] in Blood
6
42
1.43
0.35
1.5
1.9
kpa
9.6
9.7
—
6
42
(3035637) Corticotropin [Mass/volume] in Plasma
6
42
1.43
0.35
1.5
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
145
0.75
0.35
1.5
1.9
g/l
1.3
1.2
0.84
11
136
(3042936) Bacteria identified in Isolate by Culture
44
388
1.15
0.34
2.2
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
234
2255
1.08
0.33
3.2
2.9
ug/l
57.9
57.4
0.04
229
2151
(3010421) pH of Blood
6
47
1.28
0.32
1.5
2.0
ph
7.4
7.4
—
6
42
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
15
186
0.80
0.31
2.5
3.3
ng/l
67.6
65.0
0.10
15
174
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
254
2460
1.08
0.31
6.1
6.1
u/l
71.8
71.7
0.01
238
2327
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
196
0.81
0.30
2.2
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
117
1103
1.08
0.28
1.7
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
116
0.77
0.27
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
58
633
0.90
0.27
1.2
1.4
titre
298.2
544.3
1.17
11
135
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
15
122
1.24
0.27
1.3
1.6
—
0.0
—
0
18
(21494755) Public health laboratory ask at order entry panel
71
657
1.10
0.26
1.2
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
267
0.85
0.26
2.2
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
127
1336
0.93
0.26
1.8
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
159
0.81
0.25
1.5
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
137
0.80
0.24
1.5
2.0
g/l
0.2
0.2
0.19
11
129
(3005719) IgG [Mass/volume] in Serum or Plasma
22
254
0.86
0.24
1.8
2.5
g/l
10.8
10.3
0.46
22
237
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
353
3477
1.08
0.23
4.0
4.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
39
1.29
0.23
1.0
1.2
mg/l
37.7
29.0
—
5
28
(3016018) Differential panel - Cerebral spinal fluid
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
92
0.76
0.22
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
41
1.22
0.22
1.4
1.6
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
17.8
—
0
10
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
5.9
—
0
12
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
7.1
—
0
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
11
89
1.24
0.21
2.7
2.0
%
12.9
13.2
0.43
11
89
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
2.1
—
0
13
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
35
385
0.90
0.20
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
79
748
1.07
0.18
1.5
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
62
1.13
0.17
1.9
3.8
—
191.4
—
0
5
(3045424) Erythrocytes [Presence] in Urine
5
66
0.75
0.17
2.0
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
68
0.73
0.17
1.0
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
185
1803
1.05
0.15
5.0
5.3
e9/l
0.5
0.5
0.60
169
1616
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
119
0.84
0.15
2.3
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
88
842
1.06
0.15
3.4
4.3
inr
1.0
1.0
0.12
19
306
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
11
93
1.19
0.14
1.0
1.0
—
0.1
—
0
18
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
90
0.77
0.14
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
41
439
0.93
0.14
3.2
2.5
ng/l
1095.6
548.1
0.20
21
184
(3006315) Basophils [#/volume] in Blood
185
1810
1.04
0.13
5.0
5.3
e9/l
0.0
0.0
1.91
170
1615
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
330
3332
0.96
0.11
6.3
7.3
ml/min/173m2
93.8
94.8
0.43
258
2686
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.0
—
0.2
—
0
8
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
57
594
0.95
0.09
2.4
2.3
ug/g
66.0
71.6
0.16
44
463
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
97
1.14
0.09
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
56
1.07
0.08
1.2
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
58
1.03
0.08
2.0
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.4
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
62
0.80
0.08
1.0
1.1
—
7783.7
—
0
16
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
64
1.10
0.08
1.3
1.3
nmol/l
0.8
2.2
—
7
55
(3052851) Hemolysis interference index of Serum or Plasma
7
68
1.03
0.08
3.1
2.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
285
0.94
0.07
1.2
1.3
—
19.8
—
0
11
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
93
0.86
0.07
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
138
1.09
0.06
1.3
2.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
190
1880
1.02
0.05
5.0
5.3
e9/l
2.0
2.0
0.14
177
1709
(3013115) Eosinophils [#/volume] in Blood
191
1890
1.02
0.05
5.0
5.7
e9/l
0.2
0.2
1.43
178
1713
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
45
464
0.97
0.05
1.1
1.2
iu/ml
162.2
162.1
0.00
27
197
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
403
0.96
0.04
3.2
2.4
e6/l
5.7
5.6
0.02
19
205
(1002224) Polysomnography panel
22
210
1.05
0.03
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
290
0.96
0.03
2.0
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
273
2719
1.01
0.02
2.5
2.7
u/l
36.3
31.2
0.78
261
2635
(3000764) Benzodiazepines [Presence] in Urine
28
288
0.97
0.02
2.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
288
0.97
0.02
2.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
273
1.03
0.01
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
19
196
0.97
0.00
1.8
1.8
g/l
1.2
1.4
0.99
19
186
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
105
1.05
0.00
2.9
2.5
ng/l
47.0
77.0
1.28
11
94
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
155
0.97
0.00
1.8
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
252
0.99
0.00
1.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
52
521
1.00
0.00
2.1
2.4
mosm/kgh2o
522.2
536.3
0.17
46
448
(3027944) Amphetamines [Presence] in Urine
28
283
0.99
0.00
2.0
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
28
275
1.02
0.00
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
89
894
0.99
0.00
5.1
5.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.3
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.7
—
124.4
—
0
6
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.3
—
51.6
—
0
6
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
2.7
—
1.2
—
0
9
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
3.4
—
0
5
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
4.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
78
0.90
0.00
3.3
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
9
0.00
0.00
0.0
3.1
—
4.4
—
0
9
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4268621)
6
61
0.98
0.00
2.8
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
2.1
—
44.2
—
0
8
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.6
—
1.2
—
0
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
81
0.99
0.00
1.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
1.4
—
0.9
—
0
8
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.4
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_MATERN_HYPERT_UNS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have O15_MATERN_HYPERT_UNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: O15_MATERN_HYPERT_UNS – Unspecified maternal hypertension
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data